The hypercalcemia of malignancy: Pathogenesis and management

Gregory R. Mundy, T. John Martin

Research output: Contribution to journalReview articlepeer-review

255 Scopus citations


The number of agents and treatment regimens which can be used in the medical treatment of hypercalcemia has increased markedly over the last 5 yr. As this list has increased, clinicians are anxious to know more about the humoral and cellular mechanisms which are responsible for the hypercalcemia of malignancy and to understand how these drugs work. Unfortunately there is no treatment available presently which is uniformally safe and effective, and the potential pathogenetic mechanisms responsible for hypercalcemia are hotly debated. In this review, we plan to summarize current views of the pathogenesis, clinical features and treatment of hypercalcemia associated with malignant disease.

Original languageEnglish (US)
Pages (from-to)1247-1277
Number of pages31
Issue number12
StatePublished - Dec 1982

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology


Dive into the research topics of 'The hypercalcemia of malignancy: Pathogenesis and management'. Together they form a unique fingerprint.

Cite this